Postoperative adjuvant chemotherapy in Japanese gastric cancer patients using Doxifluridine, an intermediate metabolite of Capecitabine, and 5-Fluorouracil - randomized controlled trial

被引：0
|
作者：
Kojima, H.
Nonami, T.
Yamaguchi, A.
Manabe, T.
Fujii, Y.
Nimura, Y.
Sakamoto, J.
Nakao, A.
机构：
[1] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Aichi, Japan
[2] Aichi Med Univ, Dept Surg, Aichi, Japan
[3] Ogaki Municipal Hosp, Gifu, Japan
[4] Nagoya City Univ, Grad Sch Med Sci, Aichi, Japan
[5] Nagoya City Univ, Grad Sch Med Sci, Aichi, Japan
[6] Nagoya City Univ, Grad Sch Med Sci, Aichi, Japan
[7] Nagoya Univ, Dept Surg 1, Aichi, Japan
[8] Kyoto Univ, Dept Epidemiol, Clin Res Informat Management, Kyoto, Japan
[9] Nagoya Univ, Dept Surg 2, Aichi, Japan
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：211 / 211
页数：1
相关论文
共 50 条
  • [1] A prospective randomized trial comparing intravenous 5-fluorouracil and oral doxifluridine as postoperative adjuvant treatment for advanced rectal cancer
    Min, JS
    Kim, NK
    Park, JK
    Yun, SH
    Noh, JK
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (09) : 674 - 679
  • [2] A phase III randomized study comparing doxifluridine and 5-fluorouracil as supportive chemotherapy in advanced and recurrent gastric cancer
    Kondo, K
    Sakamoto, J
    Nakazato, H
    Koike, A
    Kitoh, T
    Hachisuka, K
    Saji, S
    Yura, J
    Nimura, Y
    Hamajima, N
    Katoh, K
    Yamaguchi, A
    Miya, K
    Yamauchi, M
    Mizuno, I
    Nagino, M
    Takagi, H
    [J]. ONCOLOGY REPORTS, 2000, 7 (03) : 485 - 490
  • [3] Postoperative adjuvant chemoradiation using oral capecitabine and 5-fluorouracil, cisplatin (FP) in completely resected locally advanced gastric cancer
    Kwon, HC
    Kim, MC
    Kim, SH
    Kim, JS
    Lee, HS
    Choi, SR
    Jeong, JS
    Jung, GJ
    Kim, HJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 348S - 348S
  • [4] An Immunoassay Method for the Pharmacokinetics of 5-Fluorouracil in Patients with Gastric Cancer Administered Adjuvant Chemotherapy
    Matsumoto, Hideo
    Higashida, Masaharu
    Kubota, Hisako
    Murakami, Haruaki
    Tsutsumi, Kosuke
    Nakashima, Hiroshi
    Oka, Yasuo
    Okumura, Hideo
    Nakamura, Masafumi
    Hirai, Toshihiro
    [J]. ANTICANCER RESEARCH, 2012, 32 (11) : 5111 - 5114
  • [5] A Prospective Randomized Trial Comparing Intravenous 5- Fluorouracil and Oral Doxifluridine As Postoperative Adjuvant Treatment for Advanced Rectal Cancer
    Jin Sik Min
    Nam Kyu Kim
    Jea Kun Park
    Seong Hyun Yun
    Jae Kyung Noh
    [J]. Annals of Surgical Oncology, 2000, 7 : 674 - 679
  • [6] A phase II study of weekly paclitaxel and doxifluridine (an intermediate metabolite of capecitabine) combination chemotherapy for advanced/recurrent gastric cancer
    Takeyoshi, I.
    Makita, F.
    Tanahashi, Y.
    Iwazaki, S.
    Nakamura, S.
    Ishikawa, H.
    Ogawa, T.
    Ohya, T.
    Kawate, S.
    Horiguchi, J.
    Morishita, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial
    Cascinu, Stefano
    Labianca, Roberto
    Barone, Carlo
    Santoro, Armando
    Carnaghi, Carlo
    Cassano, Alessandra
    Beretta, Giordano D.
    Catalano, Vincenzo
    Bertetto, Oscar
    Barni, Sandro
    Frontini, Luciano
    Aitini, Enrico
    Rota, Silvia
    Torri, Valter
    Floriani, Irene
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (08) : 601 - 607
  • [8] Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer
    Iwagaki, H
    Tanaka, N
    Esato, K
    Kaibara, N
    Sano, K
    Dohi, K
    Nakamura, T
    Nakasato, H
    Orita, K
    [J]. ANTICANCER RESEARCH, 2000, 20 (5C) : 3727 - 3734
  • [9] Adjuvant Chemoradiation with 5-Fluorouracil or Capecitabine in Patients with Gastric Cancer after D2 Nodal Dissection
    Osti, Mattia Falchetto
    Agolli, Linda
    Bracci, Stefano
    Monaco, Flavia
    Tubin, Slavisa
    Minniti, Giuseppe
    De Sanctis, Vitaliana
    Enrici, Riccardo Maurizi
    [J]. ANTICANCER RESEARCH, 2012, 32 (04) : 1397 - 1402
  • [10] A phase II study of weekly paclitaxel and doxifluridine (an intermediate metabolite of capecitabine) combination chemotherapy for advanced/recurrent gastric cancer.
    Takeyoshi, I
    Makita, F
    Tanahashi, Y
    Iwazaki, S
    Nakamura, S
    Ogawa, T
    Ishikawa, H
    Ohya, T
    Kawate, S
    Morishita, Y
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 328S - 328S
12345